thelancet.com/journals/lanre…

OK, Team: TWO MORE DAYS til #ACC24 ! Amazing to see it coming together after much anticipation. Took a hard hat tour of the convo center yesterday. Without giving away too much of the surprise, I’ve posted a couple choice photos of the work in progress. Great experiences ahead!

Big screen #ACC24 Fatima Rodriguez 👏🏽👏🏽👏🏽👏🏽 Stanford Medicine

Palliative care is consulted in ~1/3 of c-shock pts w/ fatal outcome in CICU, w/ wide variation by site. Palliative care consult was a/w ↑ likelihood of transition to CMO prior to death Danny McClintick, MD Critical Care Cardiology Trials Network @Ebohula @DDBergMD #ACC24

The TIMI Talks Podcast hosts are looking forward to meeting you! Stop by the TIMI Booth (#1940) at 11am on Sunday for coffee, muffins and podcast swag! Nicholas Marston David Berg #ACC24

Terrific talk by Erin Bohula on complications with MCS devices #ACC24 Sandeep Nathan, MD, MSc Frederick Welt Angela Lowenstern Jason Wollmuth David Berg Brian Bergmark

Primary results from Bridge-TIMI 73a Late Breaking Clinical Trial presented by Brian Bergmark at #ACC24 show that #olezarsen reduces #triglyceride levels by ~50% without major safety concerns. Now published in NEJM. Nicholas Marston

See Sid M. Patel present his moderated poster on early changes in vasoactive support and mortality in cardiogenic shock, 9:30am tomorrow in Moderated Poster Theater 09 @ddbergmd @Ebohula Critical Care Cardiology Trials Network #ACC24

TIMI Talks Podcast meetup in 1 hr! Meet co-hosts Nicholas Marston David Berg at Booth #1940 for coffee, muffins, podcast swag and to discuss your ideas for upcoming episodes! #ACC24

TIMI Talks Podcast meetup happening now! Booth 1940 #ACC24 Nicholas Marston David Berg

As you said 👋 to #ISHLT2024, check out 👇 our 1st #MGB Heart Failure & Shock course 9/12-14/24 in Boston, MA. Loved talks on #cardiogenicshock? More on the PACCS trial? Come to Boston! cmecatalog.hms.harvard.edu/mass-general-b… The ISHLT Harvard Medical School Mass General Heart

Excellent 1st session David Berg #IM2024 literally hit the ground running

More behind the scenes at ACP #IM2024, this time with David Berg as he discusses key takeaways from his session on acute coronary syndrome🫀 Check out the interview here: hcplive.com/view/david-ber…

Join us for our session, "Diabetes and CVD" with our renowned speakers at the 8th Heart in Diabetes 🫀 Earn #CME credits and register now at heartindiabetes.com/registration Liz Selvin David Berg @JohnHopkinsSPH Duke Clinical Research Institute Brigham and Women's Hospital Harvard Medical School TIMI Study Group American Heart Association #HID2024

In this article I define ‘Cardiopulmonary Risk’ in COPD as The risk of serious respiratory &/or CV events, including but not limited to: #COPD exacerbations #heartattack #stroke #heartfailure decompensation #arrhythmia #death due to any of these events link.springer.com/article/10.100…

The ever-enthusiastic Carlos L. Alviar MD, FACC will give his take on how #teamworkmakesthedreamwork 💥🔥4 DAYS AWAY🔥💥 bit.ly/NYUAHF24 Free for ANY trainee Code: 21824resifellow 50% off for attendings Code: 21824local   Endorsed by #HFSA #shock #CardioTwitter

Dr. Brian Bergmark joins Nicholas Marston and David Berg for the final episode of Season 2 of #TIMITalks, to discuss the Bridge-TIMI 73a trial and triglyceride lowering therapies. Listen on all major podcast platforms.

Great addition to your weekend, Dr. David Berg and Dr. Connor O'Brien blog on the value of biomarkers in cardiogenic shock is out now. Make sure to check it out! ccc1stop.com/blog Ann Gage Elliott Miller Jason N. Katz BalimSenman @Criticalecho Saraschandra Vallabhajosyula, MD MSc

The pre-shock ↔️ classic cardiogenic #shock continuum 💡What are the implications of an isolated low CO or isolated hypotension without end-organ injury? 💡 What about normotensive CS? Now in JACC Journals #JACCJF from Critical Care Cardiology Trials Network TIMI Study Group jacc.org/doi/10.1016/j.…

🔥🔥 ☠️ for phenotypes along preshock -> CS continuum 👉 jacc.org/doi/full/10.10… JACC Journals #JACCHF Critical Care Cardiology Trials Network 🎯 Hypoperfusion +/- hypotension -> ⬆️☠️ 🎯 normotensive CS -> distinct CS phenotype 🎯 Identify pre-& early shock to improve #CardiogenicShock outcomes